11.37 -0.34 (-2.90%)
DXCM
| Trade DXCM now with |
|
Stock Details
Last Trade:11.37 Change:-0.34 (-2.90%) Prev Close:11.71 Open: 11.72 Days Range:11.31 – 11.82 52 Week Range: 6.75 - 16.91 Volume:363483 P/E: N/AEPS:-0.66
View AllRecent Alerts 02/09/12
Recent Alert on 02/07/12 at 8:39am
Canaccord Genuity on Life Sciences/Biomedical Devices and Services: Take on Q4 and Beyond
Canaccord Genuity on Life Sciences/Biomedical Devices and Services: Take on Q4 and Beyond
Canaccord Genuity on Life Sciences/Biomedical Devices and Services: Dynamics of the diabetes industry into 2012: our take on Q4/11 and beyond Analyst, William J. Plovanic, said, "Heading into the Q4/11 earnings season for diabetes technology and... Read More
Recent Alert on 01/17/12 at 11:27am
Notable Analyst Rating Changes 01/17: (TSLA) (WYNN) (AMAT) Upgraded; (INTC) (PM) (RYL) Downgraded
Notable Analyst Rating Changes 01/17: (TSLA) (WYNN) (AMAT) Upgraded; (INTC) (PM) (RYL) Downgraded
Recent Alert on 01/17/12 at 7:30am
Brean Murray Carret & Co. Starts DexCom (DXCM) at Buy; Sensing a Better Year Ahead
Brean Murray Carret & Co. Starts DexCom (DXCM) at Buy; Sensing a Better Year Ahead
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 01/06/12 at 1:19pm
Pure Play Diabetes Technology Companies Offer Little To No Value For Investor
Pure Play Diabetes Technology Companies Offer Little To No Value For Investor
Blog Posts on 09/26/11 at 5:30pm
Edwards Lifesciences' Market Value Implies Strong Underlying Growth
Edwards Lifesciences' Market Value Implies Strong Underlying Growth